Automating Business Process via MuleSoft Composer | Bangalore MuleSoft Meetup...
Innovations-Investment, Processes, and Outcomes_Kureshy_5.11.11
1. Child Survival and Health Grants Program: INGO led Innovation and Operations Research (2008 – 2011) Nazo Kureshy, Team Leader, CSHGP Office of Health, Infectious Diseases and Nutrition Bureau for Global Health USAID
2.
3.
4.
5.
6.
7.
8. ANATOMY OF CSHGP’s EVALUATION CRITERIA FOR INNOVATION (2008-2011) 2008 2009 2010 2011 28 points 30 points 36 points 35 points *Rationale and capacity to address key barriers *Focused description /rationale for innovation * Contribution to evidence base/furthering policy/scale up *Problem/relationship to national context *Prior research * Appropriate solution *Problem/relevance/prior research * Unconventional * Potential for Impact, sustainability, scalability *Methodology to evaluate innovation *Mechanisms to share evidence *Proposed OR design, including research questions *OR partner/demonstrated capacity * OR objectives, questions, and other design components * OR questions only * Stakeholder engagement in research and use of information (USAID Mission)
9.
10.
11. IDEAS ACROSS USAID INNOVATION MECHANISMS CSHGP Development Innovation Ventures (DIV) Grand Challenge: Saving Lives at Birth New teaming at community level for CCM Range of Task Shifting/Performance/Motivation Maternity Waiting Homes MHealth (Dimagi comm care app) Care Group model People’s Institute Model Simplified HFP-ENA model EONC network Inventory credit (bankers and farmers) E-bike Test for pre-eclampsia Mobile phones (Dimagi comm care app for maternal health; election fraud; mobile diagnosis) TBD
12.
13.
Editor's Notes
2011: Guidance and criteria for innovation category have been aligned with the principles and priorities of USAID’s broader strategies for innovation and research and strengthened to ensure that proposed innovative solutions represent bold, new ideas, designed with scalability and sustainability considerations in local/national health systems; and, the proposed research questions are relevant to key national and local stakeholder needs 2008 Clear description and presentation of innovation and a strong rationale for the capacity of the innovation to address key barriers (e.g. access, quality, equity, sustainability) to improving health outcomes, and its contribution to strengthening the health system and furthering national policy and/or strategy direction. ( 15 points ) Clear presentation of methodology to evaluate the innovation (e.g. feasibility, cost effectiveness, potential for scale up/replication) and an appropriate timeline. (8 points) Clear presentation of mechanisms to share evidence and utilize lessons with key stakeholders to inform replication and scale up of innovation. (5 points) 2009 Scoring for Innovation Section (30 points) – Innovation Category Innovation Category Applicants can earn up to 30 points for Innovation. All sub-criteria are weighted equally. Five main elements are considered: Clear and focused description of the innovation; strong rationale for the capacity of the innovation to address critical delivery challenges and strengthen health systems. Demonstration of innovation’s potential contribution to global and/or national evidence base; to furthering national policy, and/or to be taken to scale by national programs. Proposed Operations Research (OR) design—including research question(s)—is adequate and appropriate to assess the innovation. Clear description of processes that applicant will engage in to influence national policy or national scale of innovation, based on results. Appropriate choice of “OR partner” or demonstrated capacity of applicant to conduct OR. 2010 Evaluation Criteria for Assessing Innovation – Innovation Category Innovation Category Applicants can earn up to 36 points for Innovation, the largest proportion of points to be earned in a single section and accounting for just over 1/3 of the total possible points (i.e. 100). Six main areas are considered, so please consider these in your assessment and consider the strengths and weaknesses of what is being put forward in this section: Clear and focused description of the problem (operational barriers), including a rationale for its prioritization and relationship to programs and/or policies in-country. Clear description of prior efforts to research and address the identified problem within the proposed context and/or globally, including any major unanswered questions pertaining to the problem and proposed innovation. Demonstration that the proposed innovation is an appropriate solution for improving and scaling-up the delivery of high impact MNCH interventions and will adequately address the identified problem. OR objective(s), question(s), and other design components are clearly articulated, prioritized, and feasible for generating credible evidence for the innovation.